RIGEL PHARMACEUTICALS, INC. Financing Cash Flow
RIGEL PHARMACEUTICALS, INC. (RIGL) reported Financing Cash Flow of -$22.62 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-04
- RIGEL PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$11.70M, a 2899.28% decline year-over-year.
- RIGEL PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$10.92M, a 2355.99% decline year-over-year.
- RIGEL PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$4.57M, a 412.08% decline year-over-year.
- RIGEL PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $4.27M.
- RIGEL PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2025 was $601.00K.
- RIGEL PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2024 was -$11.64M, a 163.38% decline from fiscal 2023.
- RIGEL PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2023 was $18.37M, a 180.41% increase from fiscal 2022.
- RIGEL PHARMACEUTICALS, INC. net cash provided by (used in) financing activities for fiscal 2022 was $6.55M, a 89.55% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$11.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$22.62M 10-Q · filed 2026-08-04 | -$27.19M derived: sum of 3 quarters · filed 2026-08-04 | -$22.92M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$10.92M 10-Q · filed 2026-05-05 | -$15.49M derived: sum of 2 quarters · filed 2026-05-05 | -$11.22M derived: sum of 3 quarters · filed 2026-05-05 | -$10.80M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$4.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$301.00K derived: sum of 2 quarters · filed 2026-03-03 | $117.00K derived: sum of 3 quarters · filed 2026-08-04 | $601.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | $4.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $4.69M derived: sum of 2 quarters · filed 2026-08-04 | $5.17M 10-Q · filed 2025-11-04 | $6.64M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $418.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $902.00K 10-Q · filed 2026-08-04 | $2.37M derived: sum of 3 quarters · filed 2026-08-04 | -$7.47M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $484.00K 10-Q · filed 2026-05-05 | $1.95M derived: sum of 2 quarters · filed 2026-05-05 | -$7.89M derived: sum of 3 quarters · filed 2026-05-05 | -$8.64M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$8.38M derived: sum of 2 quarters · filed 2026-03-03 | -$9.13M derived: sum of 3 quarters · filed 2026-03-03 | -$11.64M 10-K · filed 2026-03-03 |
| 2024-09-30 | -$9.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$10.59M derived: sum of 2 quarters · filed 2025-11-04 | -$13.11M 10-Q · filed 2025-11-04 | -$12.62M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | -$752.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$3.26M 10-Q · filed 2025-08-05 | -$2.78M derived: sum of 3 quarters · filed 2026-03-03 | -$3.65M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | -$2.51M 10-Q · filed 2025-05-06 | -$2.03M derived: sum of 2 quarters · filed 2026-03-03 | -$2.90M derived: sum of 3 quarters · filed 2026-03-03 | -$3.27M derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | $486.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$383.00K derived: sum of 2 quarters · filed 2026-03-03 | -$756.00K derived: sum of 3 quarters · filed 2026-03-03 | $18.37M 10-K · filed 2026-03-03 |
| 2023-09-30 | -$869.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.24M derived: sum of 2 quarters · filed 2024-11-07 | $17.88M 10-Q · filed 2024-11-07 | $15.79M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | -$373.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $18.75M 10-Q · filed 2024-08-06 | $16.65M derived: sum of 3 quarters · filed 2025-03-04 | $22.16M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | $19.12M 10-Q · filed 2024-05-07 | $17.03M derived: sum of 2 quarters · filed 2025-03-04 | $22.54M derived: sum of 3 quarters · filed 2025-03-04 | $16.88M derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | -$2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $3.42M derived: sum of 2 quarters · filed 2025-03-04 | -$2.25M derived: sum of 3 quarters · filed 2025-03-04 | $6.55M 10-K · filed 2025-03-04 |
| 2022-09-30 | $5.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$151.00K derived: sum of 2 quarters · filed 2023-11-07 | $8.65M 10-Q · filed 2023-11-07 | $9.73M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | -$5.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $3.13M 10-Q · filed 2023-08-01 | $4.22M derived: sum of 3 quarters · filed 2024-03-05 | $4.49M derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $8.80M 10-Q · filed 2023-05-02 | $9.88M derived: sum of 2 quarters · filed 2024-03-05 | $10.16M derived: sum of 3 quarters · filed 2024-03-05 | $69.38M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $1.36M derived: sum of 2 quarters · filed 2024-03-05 | $60.58M derived: sum of 3 quarters · filed 2024-03-05 | $62.67M 10-K · filed 2024-03-05 |
| 2021-09-30 | $274.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $59.49M derived: sum of 2 quarters · filed 2022-11-03 | $61.59M 10-Q · filed 2022-11-03 | $62.26M derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-06-30 | $59.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $61.32M 10-Q · filed 2022-08-02 | $61.98M derived: sum of 3 quarters · filed 2023-03-07 | $62.03M derived: sum of 4 quarters · filed 2023-03-07 |
| 2021-03-31 | $2.10M 10-Q · filed 2022-05-03 | $2.76M derived: sum of 2 quarters · filed 2023-03-07 | $2.82M derived: sum of 3 quarters · filed 2023-03-07 | $13.33M derived: sum of 4 quarters · filed 2023-03-07 |
| 2020-12-31 | $667.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $719.00K derived: sum of 2 quarters · filed 2023-03-07 | $11.23M derived: sum of 3 quarters · filed 2023-03-07 | $12.57M 10-K · filed 2023-03-07 |
| 2020-09-30 | $52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $10.57M derived: sum of 2 quarters · filed 2021-11-02 | $11.90M 10-Q · filed 2021-11-02 | $12.60M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $10.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $11.85M 10-Q · filed 2021-08-03 | $12.55M derived: sum of 3 quarters · filed 2022-03-01 | $22.34M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $1.34M 10-Q · filed 2021-05-05 | $2.03M derived: sum of 2 quarters · filed 2022-03-01 | $11.83M derived: sum of 3 quarters · filed 2022-03-01 | $12.69M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $694.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $10.49M derived: sum of 2 quarters · filed 2022-03-01 | $11.35M derived: sum of 3 quarters · filed 2022-03-01 | $11.37M 10-K · filed 2022-03-01 |
| 2019-09-30 | $9.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $10.65M derived: sum of 2 quarters · filed 2020-11-05 | $10.67M 10-Q · filed 2020-11-05 | $11.77M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-06-30 | $856.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $872.00K 10-Q · filed 2020-08-04 | $1.97M derived: sum of 3 quarters · filed 2021-03-02 | $2.61M derived: sum of 4 quarters · filed 2021-03-02 |
| 2019-03-31 | $16.00K 10-Q · filed 2020-05-05 | $1.11M derived: sum of 2 quarters · filed 2021-03-02 | $1.75M derived: sum of 3 quarters · filed 2021-03-02 | $69.90M derived: sum of 4 quarters · filed 2021-03-02 |
| 2018-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $1.73M derived: sum of 2 quarters · filed 2021-03-02 | $69.88M derived: sum of 3 quarters · filed 2021-03-02 | $71.89M 10-K · filed 2021-03-02 |
| 2018-09-30 | $635.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $68.78M derived: sum of 2 quarters · filed 2019-11-05 | $70.80M 10-Q · filed 2019-11-05 | $138.16M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $68.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $70.16M 10-Q · filed 2019-08-06 | $137.53M derived: sum of 3 quarters · filed 2020-02-27 | $140.86M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $2.01M 10-Q · filed 2019-05-07 | $69.38M derived: sum of 2 quarters · filed 2020-02-27 | $72.71M derived: sum of 3 quarters · filed 2020-02-27 | $76.28M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $67.37M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $70.70M derived: sum of 2 quarters · filed 2020-02-27 | $74.26M derived: sum of 3 quarters · filed 2020-02-27 | $117.69M 10-K · filed 2020-02-27 |
| 2017-09-30 | $3.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $6.90M derived: sum of 2 quarters · filed 2018-11-06 | $50.32M 10-Q · filed 2018-11-06 | $52.36M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $3.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $46.98M 10-Q · filed 2018-08-08 | $49.02M derived: sum of 3 quarters · filed 2019-02-28 | $62.20M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $43.42M 10-Q · filed 2018-05-01 | $45.46M derived: sum of 2 quarters · filed 2019-02-28 | $58.64M derived: sum of 3 quarters · filed 2019-02-28 | |
| 2016-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $15.22M derived: sum of 2 quarters · filed 2019-02-28 | $25.18M 10-K · filed 2019-02-28 | |
| 2016-09-30 | $13.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $23.15M 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $9.97M 10-Q · filed 2017-08-01 | |||
| 2015-12-31 | $7.05M 10-K · filed 2018-03-06 | |||
| 2011-06-30 | $141.19M 10-Q · filed 2011-08-02 | |||
| 2010-06-30 | $348.00K 10-Q · filed 2011-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |